Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Change in Receivables (2023 - 2026)

Krystal Biotech's Change in Receivables history spans 4 years, with the latest figure at -$58000.0 for Q1 2026.

  • On a quarterly basis, Change in Receivables rose 96.1% to -$58000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $23.6 million, a 58.53% decrease, with the full-year FY2025 number at $22.1 million, down 64.72% from a year prior.
  • Change in Receivables hit -$58000.0 in Q1 2026 for Krystal Biotech, up from -$2.5 million in the prior quarter.
  • Over the last five years, Change in Receivables for KRYS hit a ceiling of $56.8 million in Q2 2024 and a floor of -$5.9 million in Q3 2024.
  • Historically, Change in Receivables has averaged $11.5 million across 4 years, with a median of $7.4 million in 2024.
  • Biggest five-year swings in Change in Receivables: plummeted 163.75% in 2024 and later skyrocketed 401.78% in 2025.
  • Tracing KRYS's Change in Receivables over 4 years: stood at $32.7 million in 2023, then plummeted by 77.24% to $7.4 million in 2024, then crashed by 133.45% to -$2.5 million in 2025, then soared by 97.67% to -$58000.0 in 2026.
  • Business Quant data shows Change in Receivables for KRYS at -$58000.0 in Q1 2026, -$2.5 million in Q4 2025, and $17.9 million in Q3 2025.